Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
- 171 Downloads
Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of cancer in India with high incidence and rapid recurrence rates. Here, we aimed to investigate the role of β-catenin, a developmental pathway gene, in HNSCC therapy resistance, DNA damage response, recurrence and prognosis.
In total 80 HNSCC samples were included. Western blot, immunohistochemistry and qRT-PCR analyses were performed to assess β-catenin expression in the cut margin and tumor areas of each sample. Kaplan-Meier analyses were performed to correlate β-catenin expression with the survival and prognosis of HNSCC patients. In addition, chemo-resistance, DNA damage response and DNA repair capacities were evaluated in HNSCC-derived cell lines through LiCl-mediated up-regulation and siRNA-mediated silencing of β-catenin expression.
We observed β-catenin up-regulation in cut margin areas of recurrent patients compared to their corresponding tumor regions, which subsequently could be associated with poor prognosis. In addition, we found that LiCl-mediated up-regulation of β-catenin in HNSCC-derived cells led to cisplatin resistance, evasion of apoptosis, enhanced DNA repair and enhanced migration. The effects of β-catenin silencing correlated with its putative role in chemo-resistance and DNA damage response.
From our results we conclude that β-catenin may contribute to HNSCC therapy resistance and disease relapse. As such, β-catenin may be explored as a therapeutic target along with conventional therapeutics.
KeywordsHead and neck squamous cell carcinoma (HNSCC) β catenin Cisplatin-resistance Disease relapse DNA damage repair and response Prognosis
This work was supported by a grant from the Department of Atomic Energy (DAE), Board of Research for Nuclear Sciences (BRNS), Government of India, Grant Number 2013/35/45/BRNS and by the MSSB (Molecular Stress and Stem Cell Biology) group.
Compliance with ethical standard
This study was approved by the institutional ethics committee of the School of Biotechnology and Kalinga Institute of Medical Sciences (KIMS), KIIT University, and was conducted according to the Helsinki declaration. The human sample collection was carried out strictly according to the institutional ethical board guidelines.
Conflict of interest
The authors declare no conflict of interest.
Informed consent was obtained from all subjects or their nominees prior to participation in the study.
- 1.S. Padhi, A. Saha, M. Kar, C. Ghosh, A. Adhya, M. Baisakh, N. Mohapatra, S. Venkatesan, M.P. Hande, B. Banerjee, Clinico-pathological correlation of β-catenin and telomere dysfunction in head and neck squamous cell carcinoma patients. J Cancer 6, 192–202 (2015). https://doi.org/10.7150/jca.9558 CrossRefPubMedPubMedCentralGoogle Scholar
- 5.S. Ghuwalewala, D. Ghatak, P. Das, S. Dey, S. Sarkar, N. Alam, C.K. Panda, S. Roychoudhury, CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma. Stem Cell Res 16, 405–417 (2016). https://doi.org/10.1016/j.scr.2016.02.028 CrossRefPubMedGoogle Scholar
- 7.S. Bhattacharyya, V. Sekar, B. Majumder, D.G. Mehrotra, S. Banerjee, A.K. Bhowmick, N. Alam, G.K. Mandal, J. Biswas, P.K. Majumder, N. Murmu, CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer. Cell Oncol 40, 145–155 (2017). https://doi.org/10.1007/s13402-016-0311-7 CrossRefGoogle Scholar
- 8.I.P. Ribeiro, F. Caramelo, F. Marques, A. Domingues, M. Mesquita, L. Barroso, H. Prazeres, M.J. Juliao, I.P. Baptista, A. Ferreira, J.B. Melo, I.M. Carreira, WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report. Cell Oncol 39, 573–582 (2016). https://doi.org/10.1007/s13402-016-0293-5 CrossRefGoogle Scholar
- 9.L. Kadletz, G. Heiduschka, R. Wiebringhaus, E. Gurnhofer, U. Kotowski, G. Haymerle, M. Brunner, C. Barry, L. Kenner, ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report. Cell Oncol 40, 193–198 (2017). https://doi.org/10.1007/s13402-016-0310-8 CrossRefGoogle Scholar
- 12.E.M.F. de Sousa, L. Vermeulen, Wnt signaling in cancer stem cell biology. Cancers 8 (2016). doi: https://doi.org/10.3390/cancers8070060
- 16.M. Kabatkova, O. Zapletal, Z. Tylichova, J. Neca, M. Machala, A. Milcova, J. Topinka, A. Kozubik, J. Vondracek, Inhibition of beta-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation. Mutagenesis 30, 565–576 (2015). https://doi.org/10.1093/mutage/gev019 CrossRefPubMedGoogle Scholar
- 17.A. Saha, S. Padhi, M. Kar, S. Roy, P. Maiti, B. Banerjee, Role of TRF2 in efficient DNA repair, spheroid formation and cancer stem cell maintenance. Oncomedicine 2, 71–79 (2017). https://doi.org/10.7150/oncm.18373
- 20.J.P. Newman, B. Banerjee, W. Fang, A. Poonepalli, L. Balakrishnan, G.K. Low, R.N. Bhattacharjee, S. Akira, M. Jayapal, A.J. Melendez, R. Baskar, H.W. Lee, M.P. Hande, Short dysfunctional telomeres impair the repair of arsenite-induced oxidative damage in mouse cells. J Cell Physiol 214, 796–809 (2008). https://doi.org/10.1002/jcp.21276 CrossRefPubMedGoogle Scholar
- 22.D.R. Rhodes, S. Kalyana-Sundaram, V. Mahavisno, R. Varambally, J. Yu, B.B. Briggs, T.R. Barrette, M.J. Anstet, C. Kincead-Beal, P. Kulkarni, S. Varambally, D. Ghosh, A.M. Chinnaiyan, Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166–180 (2007). https://doi.org/10.1593/neo.07112 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.M.A. Ginos, G.P. Page, B.S. Michalowicz, K.J. Patel, S.E. Volker, S.E. Pambuccian, F.G. Ondrey, G.L. Adams, P.M. Gaffney, Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64, 55–63 (2004). https://doi.org/10.1158/0008-5472.CAN-03-2144 CrossRefPubMedGoogle Scholar
- 24.C.H. Peng, C.T. Liao, S.C. Peng, Y.J. Chen, A.J. Cheng, J.L. Juang, C.Y. Tsai, T.C. Chen, Y.J. Chuang, C.Y. Tang, W.P. Hsieh, T.C. Yen, A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PloS one 6, e23452 (2011). https://doi.org/10.1371/journal.pone.0023452 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.A. Cromer, A. Carles, R. Millon, G. Ganguli, F. Chalmel, F. Lemaire, J. Young, D. Dembele, C. Thibault, D. Muller, O. Poch, J. Abecassis, B. Wasylyk, Dentification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23, 2484–2498 (2004). https://doi.org/10.1038/sj.onc.1207345 CrossRefPubMedGoogle Scholar
- 28.E. Beurel, M. Kornprobst, M.J. Blivet-Van Eggelpoel, C. Ruiz-Ruiz, A. Cadoret, J. Capeau, C. Desbois-Mouthon, GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. Exp Cell Res 300, 354–364 (2004). https://doi.org/10.1016/j.yexcr.2004.08.001 CrossRefPubMedGoogle Scholar
- 30.Padhi SS, Kar M, Saha A, Baisakh MR, Mohapatra N, Banerjee BN. Rapid recurrence and poor prognosis with altered levels of β-catenin in 3 cases of head and neck squamous cell carcinoma patients. Head Neck Oncol 6, 39 (2014)Google Scholar
- 31.Y. Yamano, K. Uzawa, K. Saito, D. Nakashima, A. Kasamatsu, H. Koike, Y. Kouzu, K. Shinozuka, K. Nakatani, K. Negoro, S. Fujita, H. Tanzawa, Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. Int J Cancer 126, 437–449 (2010). https://doi.org/10.1002/ijc.24704 CrossRefPubMedGoogle Scholar
- 33.M.K. Mohammed, C. Shao, J. Wang, Q. Wei, X. Wang, Z. Collier, S. Tang, H. Liu, F. Zhang, J. Huang, D. Guo, M. Lu, F. Liu, J. Liu, C. Ma, L.L. Shi, A. Athiviraham, T.C. He, M.J. Lee, Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 3, 11–40 (2016). https://doi.org/10.1016/j.gendis.2015.12.004 CrossRefPubMedPubMedCentralGoogle Scholar
- 34.N. Kneidinger, A.O. Yildirim, J. Callegari, S. Takenaka, M.M. Stein, R. Dumitrascu, A. Bohla, K.R. Bracke, R.E. Morty, G.G. Brusselle, R.T. Schermuly, O. Eickelberg, M. Konigshoff, Activation of the WNT/beta-catenin pathway attenuates experimental emphysema. Am. J. Respir. Crit. Care Med. 183, 723–733 (2011). https://doi.org/10.1164/rccm.200910-1560OC CrossRefPubMedGoogle Scholar